Compile Data Set for Download or QSAR
maximum 50k data
Found 96 Enz. Inhib. hit(s) with Target = 'RNA-directed RNA polymerase L'
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM412212(Step h | US10398706, Example 1)
Affinity DataEC50: >800nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM412213(US10398706, Example 2)
Affinity DataEC50: >800nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM412214(US10398706, Example 3)
Affinity DataEC50: >800nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM412215(Step e | US10398706, Example 4)
Affinity DataEC50:  600nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM412216(Step c | US10398706, Example 5)
Affinity DataEC50:  600nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM412217(US10398706, Example 6 | US10398706, Example 7)
Affinity DataEC50: <400nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM412217(US10398706, Example 6 | US10398706, Example 7)
Affinity DataEC50: >800nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM412219(US10398706, Example 8 | US10398706, Example 9)
Affinity DataEC50:  600nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Respiratory syncytial virus type A)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM412219(US10398706, Example 8 | US10398706, Example 9)
Affinity DataEC50: >800nMAssay Description:Following extensive parameter testing, the final assay is run as follows: HEp-2 cells are seeded into the inner 60 wells of a 96-well plate at 8,000 ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458059(Step f | US10752598, Example 1)
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458060(US10752598, Example 2)
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458061(US10752598, Example 3)
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458062(US10752598, Example 4)
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458063(Step a | US10752598, Example 5)
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458064(Step c | US10752598, Example 6)
Affinity DataEC50:  3.50E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458065(Step e | US10752598, Example 7)
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458066(Step c | US10752598, Example 8)
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458067(Step b | US10752598, Example 9)
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458068(Step a | US10752598, Example 10)
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458069(Step a | US10752598, Example 11)
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458070(Step c | US10752598, Example 12)
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458071(Step C | US10752598, Example 13)
Affinity DataEC50:  3.50E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458072(Step c | US10752598, Example 14)
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458073(Step c | US10752598, Example 15)
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458074(Step b | US10752598, Example 16)
Affinity DataEC50: <2.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458075(Step b | US10752598, Example 17)
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458076(Step h | US10752598, Example 19)
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458077(US10752598, Example 20)
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM458078(US10752598, Example 21)
Affinity DataEC50: >5.00E+3nMAssay Description:HEp-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568384(US11420976, Example 1)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568385(US11420976, Example 2)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568386(US11420976, Example 3)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568387(US11420976, Example 4)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568388(US11420976, Example 5)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568389(US11420976, Example 6)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568390(US11420976, Example 7)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568391(US11420976, Example 8)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568392(US11420976, Example 9)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568393(US11420976, Example 10)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568394(US11420976, Example 11)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568395(US11420976, Example 12)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568396(US11420976, Example 13)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568397(US11420976, Example 14)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568398(US11420976, Example 15)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568399(US11420976, Example 16)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568400(US11420976, Example 17)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568401(US11420976, Example 18)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568402(US11420976, Example 19)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568403(US11420976, Example 20)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568404(US11420976, Example 21)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 96 total ) | Next | Last >>
Jump to: